Flucloxacillin HLA-B*5701 Liver Toxicity Risk

Calculate flucloxacillin cholestatic hepatitis risk from HLA-B*5701 carrier status.

Weight
Height
Clinical Guidance

BMI is a screening measure of body size, not a direct measure of body fat. The standard WHO categories are underweight (<18.5), normal (18.5–24.9), overweight (25–29.9), and obese (≥30).

BMI can overestimate body fat in athletes with high muscle mass and underestimate it in older adults with low muscle mass. Interpret it alongside waist circumference and clinical context rather than as a standalone diagnosis.

⚕ Clinical Disclaimer: These calculators are for educational and reference purposes only. Always verify results with qualified clinical judgment and current clinical guidelines. Do not use as a sole basis for medical decisions.
Advertisement

How It Works

Calculate flucloxacillin cholestatic hepatitis risk from HLA-B*5701 carrier status

Each component has a specific meaning:

  • HLA-B*5701 carrier status — The hla-b*5701 carrier status recorded for the scenario being assessed.

Note: Interpret the flucloxacillin hla-b*5701 result against the thresholds and context described above.

How to Use

Enter the HLA-B*5701 carrier status for the scenario you are assessing. Calculate flucloxacillin cholestatic hepatitis risk from HLA-B*5701 carrier status. Use the flucloxacillin hla-b*5701 result to inform your calculation.

Related Calculators

Abacavir HLA-B*5701

Medical Ultra-depth

Frequently Asked Questions